Table 1.
Characteristics of patients at time of identification as a methicillin-resistant Staphylococcus aureus (MRSA) prevalent carrier.
| Characteristic | No. (%) of patients (n = 281) |
|---|---|
| Sex | |
| Male | 151 (54) |
| Female | 130 (46) |
| Race | |
| White | 237 (84) |
| Black | 36 (13) |
| Other | 8 (3) |
| Age | |
| 18–44 years | 48 (17) |
| 45–54 years | 50 (18) |
| 55–64 years | 58 (21) |
| 65–74 years | 60 (21) |
| 75–84 years | 47 (17) |
| ≥85 years | 18 (6) |
| Comorbidity | |
| Diabetes mellitus | 100 (36) |
| End-stage renal disease | 29 (10) |
| End-stage liver disease | 13 (5) |
| Solid-organ cancer | 41 (15) |
| Hematologic malignancy | 14 (5) |
| Immunocompromised, noncancer | 26 (9) |
| Health care location | |
| Inpatient | 221 (79) |
| Outpatient | 60 (21) |
| Potential risk factors for MRSA infection | |
| Wound | 180 (64) |
| Intubation | 54 (19) |
| Intensive care unit admission | 39 (14) |
| Hospital admission in previous year | 191 (68) |
| Surgical procedure in previous 6 months | 110 (39) |
| Preadmission locationa,b | |
| Home | 165 (75) |
| Hospital transfer | 33 (15) |
| Rehabilitation | 9 (4) |
| Skilled nursing facility | 14 (6) |
| Discharge dispositiona,b | |
| Home | 126 (57) |
| Hospital transfer | 4 (2) |
| Rehabilitation | 60 (27) |
| Skilled nursing facility | 17 (8) |
| Deceasedc | 14 (6) |
| Time since first known evidence of MRSA positivity | |
| 1 to <2 years | 175 (62) |
| 2 to <3 years | 49 (17) |
| 3 to <4 years | 22 (8) |
| ≥4 years | 35 (16) |
a
n = 221.
b
Evaluation for admission where patient identified as prevalent carrier a with known history of MRSA ≥1 year.
c
Deaths refer to all-cause mortality during the enrollment hospitalization.